| Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma (NCT03430011) | Juno Therapeutics, a Subsidiary of Celgene | 2018-02-01 |
| Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC (NCT03525782) | The First Affiliated Hospital of Guangdong Pharmaceutical University | 2018-02-01 |
| OZONE_EXO: Comparative Analysis of Protocols for Dental Exactions in Patients at Risk of MRONJ: Case-control Study (NCT06072404) | University of Palermo | 2018-02-01 |
| Infiltration of Medical Ozone for the Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ) (NCT05036837) | University of Palermo | 2018-02-01 |
| Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency (NCT03288103) | Children's Hospital Medical Center, Cincinnati | 2018-02-01 |
| Direct Peritoneal Resuscitation in Gastroschisis (NCT03205553) | University of Arkansas | 2018-02-01 |
| Fecal Microbiota Transplantation for Eradication of CRE (NCT03167398) | Rambam Health Care Campus | 2018-02-01 |
| Phase I Drug-drug Interaction of Omega-3 and Atorvastatin (NCT03438955) | DongKoo Bio & Pharma | 2018-02-01 |
| Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis (NCT03416751) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2018-02-01 |
| Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid (NCT03309657) | Royal Brisbane and Women's Hospital | 2018-02-01 |
| Cooking for Health Optimization With Patients (NCT03443635) | Tulane University | 2018-02-01 |
| Study of Tolerance, Biodistribution and Dosimetry of Fucoidan Radiolabeled by Technetium-99m (NCT03422055) | Assistance Publique - Hôpitaux de Paris | 2018-02-01 |
| Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans (NCT03201952) | Vanderbilt University Medical Center | 2018-02-01 |
| Home Exercise With Wearable Sensors (NCT03416842) | Burke Medical Research Institute | 2018-02-01 |
| PolyTreg Immunotherapy in Islet Transplantation (NCT03444064) | University of Alberta | 2018-02-01 |
| Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers (NCT03495739) | Huons Co., Ltd. | 2018-02-01 |
| Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant (NCT03459170) | Bellicum Pharmaceuticals | 2018-02-01 |
| Effects of Dry Needling on Neck and Shoulder Pain in Orchestral Musicians: a Prospective Case Series (NCT03402867) | CEU San Pablo University | 2018-02-01 |
| Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility (NCT04071574) | Lebanese University | 2018-02-01 |
| Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults (NCT03373214) | Baylor College of Medicine | 2018-02-01 |
| 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects (NCT03424525) | University of Pennsylvania | 2018-02-01 |
| The Effect of Remote Ischemic Conditioning on the Microcirculation in Sepsis (NCT04644926) | Lithuanian University of Health Sciences | 2018-02-01 |
| Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma (NCT03297463) | Masonic Cancer Center, University of Minnesota | 2018-01-31 |
| Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies (NCT03301896) | Novartis Pharmaceuticals | 2018-01-31 |
| TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects (NCT03408470) | Theravance Biopharma | 2018-01-31 |
| Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy (NCT03404960) | University of Pennsylvania | 2018-01-31 |
| Study of Topical SOR007 Ointment for Cutaneous Metastases (NCT03101358) | NanOlogy, LLC | 2018-01-31 |
| First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) (NCT03401385) | Daiichi Sankyo Co., Ltd. | 2018-01-31 |
| Safety of 4Fluart ID Suspension for Injection in Adult Subjects (NCT03448705) | Fluart Innovative Vaccine Ltd, Hungary | 2018-01-31 |
| Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III (NCT03433222) | VA Northern California Health Care System | 2018-01-31 |
| Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors (NCT03320330) | Children's Oncology Group | 2018-01-31 |
| A Phase 1 AVB-S6-500 Safety and Tolerability Study (NCT03401528) | Aravive, Inc. | 2018-01-31 |
| An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread (NCT03377361) | Bristol-Myers Squibb | 2018-01-31 |
| A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT03328273) | Acerta Pharma BV | 2018-01-31 |
| ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers (NCT02657876) | Stratatech, a Mallinckrodt Company | 2018-01-31 |
| Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells (NCT03887208) | Medical University of Warsaw | 2018-01-31 |
| Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery (NCT03384836) | Roswell Park Cancer Institute | 2018-01-31 |
| Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer (NCT03384316) | National Cancer Institute (NCI) | 2018-01-31 |
| A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations (NCT03432195) | Corium, Inc. | 2018-01-31 |
| A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty (NCT03498261) | Ohio State University | 2018-01-30 |
| Patients With Vulvovaginal Candidiasis (NCT03024502) | University of Sao Paulo | 2018-01-30 |
| A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis (NCT03418493) | Eli Lilly and Company | 2018-01-30 |
| Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects (NCT03442244) | LEO Pharma | 2018-01-30 |
| Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis (NCT03500263) | Proteostasis Therapeutics, Inc. | 2018-01-30 |
| Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies (NCT03394144) | AstraZeneca | 2018-01-30 |
| A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade (NCT03399435) | Grünenthal GmbH | 2018-01-30 |
| Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) (NCT06103396) | Instituto Venezolano de Investigaciones Cientificas | 2018-01-30 |
| Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors (NCT03454035) | UNC Lineberger Comprehensive Cancer Center | 2018-01-30 |
| Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer (NCT03737370) | Tufts Medical Center | 2018-01-30 |
| TAS102 in Combination With NAL-IRI in Advanced GI Cancers (NCT03368963) | Emory University | 2018-01-30 |
| A Study of APX3330 in Patients With Advanced Solid Tumors (NCT03375086) | Apexian Pharmaceuticals, Inc. | 2018-01-30 |
| Transcranial Magnetic Stimulation to Improve Gesture Control (NCT03483909) | University of Bern | 2018-01-29 |
| A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis (NCT03492398) | Shaperon | 2018-01-29 |
| Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI (NCT03326245) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2018-01-29 |
| Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC (NCT03333343) | Novartis Pharmaceuticals | 2018-01-29 |
| Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm (NCT03440112) | Nicolaas Bohnen, MD, PhD | 2018-01-29 |
| Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants (NCT03242434) | GlaxoSmithKline | 2018-01-29 |
| Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects (NCT03392116) | NGM Biopharmaceuticals, Inc | 2018-01-29 |
| Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab (NCT03707808) | Universitair Ziekenhuis Brussel | 2018-01-29 |
| Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy (NCT03395873) | Milton S. Hershey Medical Center | 2018-01-29 |
| CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER) (NCT03408587) | Viralytics | 2018-01-29 |
| Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules (NCT03443960) | Tonix Pharmaceuticals, Inc. | 2018-01-29 |
| Study of Pembrolizumab Following TACE in Primary Liver Carcinoma (NCT03397654) | Imperial College London | 2018-01-28 |
| Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects (NCT03440424) | Eisai Inc. | 2018-01-26 |
| Platelet Rich Plasma Injection Versus Surgical and Medical Treatment of Mild-moderate Carpel Tunnel Syndrome. (NCT04235426) | Dalia Salah Saif | 2018-01-26 |
| A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects (NCT03586076) | JHL Biotech, Inc. | 2018-01-26 |
| HMPL-813 in Treating Patients With Glioblastoma (NCT03231501) | Hutchison Medipharma Limited | 2018-01-26 |
| Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects (NCT03519516) | Laboratorios Sophia S.A de C.V. | 2018-01-25 |
| Omega-3 Fatty Acids in Sickle Cell Disease (NCT02947100) | Robin E. Miller | 2018-01-25 |
| Therapeutic Oxygen for Gastrointestinal Atony (TOGA) (NCT03386136) | University of Florida | 2018-01-25 |
| ONC201 in Pediatric H3 K27M Gliomas (NCT03416530) | Jazz Pharmaceuticals | 2018-01-25 |
| Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (NCT03181035) | Sunnybrook Health Sciences Centre | 2018-01-25 |
| A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects (NCT03432884) | BeiGene | 2018-01-25 |
| A Study of Lasmiditan in Healthy Elderly Participants (NCT03406260) | Eli Lilly and Company | 2018-01-25 |
| A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects (NCT03398473) | Pfizer | 2018-01-25 |
| Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction (NCT04935294) | Alexion Pharmaceuticals, Inc. | 2018-01-24 |
| BT1718 in Patients with Advanced Solid Tumours. (NCT03486730) | Cancer Research UK | 2018-01-24 |
| Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers (NCT03332498) | H. Lee Moffitt Cancer Center and Research Institute | 2018-01-24 |
| Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy (NCT03508947) | Wave Life Sciences USA, Inc. | 2018-01-24 |
| Explore Effects of Dietary Fish Oil in Human Skin (NCT03122912) | University of Michigan | 2018-01-24 |
| Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study (NCT03340805) | Children's Hospital of Philadelphia | 2018-01-24 |
| A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects (NCT03430661) | Viatris Innovation GmbH | 2018-01-24 |
| A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne (NCT03450369) | Naked Biome, Inc. | 2018-01-24 |
| Effect of D-amphetamine on Reward Functioning (NCT03369015) | The University of Texas Health Science Center, Houston | 2018-01-24 |
| Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis (NCT03594981) | Catherine Bollard | 2018-01-24 |
| LAM Pilot Study With Imatinib Mesylate (NCT03131999) | Medical University of South Carolina | 2018-01-23 |
| Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease (NCT03486990) | Takeda | 2018-01-23 |
| Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (NCT03754179) | Universitair Ziekenhuis Brussel | 2018-01-23 |
| A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy (NCT03362502) | Pfizer | 2018-01-23 |
| Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL (NCT03283137) | University of Chicago | 2018-01-23 |
| Anlotinib and Irinotecan for Ewing Sarcoma (NCT03416517) | Peking University People's Hospital | 2018-01-22 |
| Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers (NCT03652792) | Lee's Pharmaceutical Limited | 2018-01-22 |
| A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia (NCT03356639) | Astellas Pharma Global Development, Inc. | 2018-01-22 |
| A Study of XmAb®18087 in Subjects With NET and GIST (NCT03411915) | Xencor, Inc. | 2018-01-22 |
| A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects (NCT03372044) | Pfizer | 2018-01-19 |
| A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers (NCT03443453) | Medivir | 2018-01-19 |
| A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol (NCT03467113) | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 2018-01-19 |
| A Pilot Bioequivalence Study of Pomalidomide (NCT03424928) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2018-01-19 |
| SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial (NCT03306680) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2018-01-19 |
| A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants (NCT04194892) | Eli Lilly and Company | 2018-01-19 |